Results 81 to 90 of about 97,001 (288)

Effect of Haemodialysis on Mean Prothrombin Time and Activated Partial Thromboplastin Time in Patients of End Stage Renal Disease

open access: yesJournal of Rawalpindi Medical College, 2015
Background: To determine mean prothrombin time and activated partial thromboplastin time in patients of end stage renal disease having normal baseline coagulation parameters after hemodialysis.
Attika Khalid
doaj  

Effect of plasma storage on prothrombin time and activated partial thromboplastin time at a Nigerian public laboratory

open access: yesSahel Medical Journal, 2013
Background: Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the tests used in the investigation and monitoring of hemostatic disorders. Plasma is used to perform these tests immediately or stored for later use.
Mohammed A Ndakotsu   +4 more
doaj   +1 more source

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. [PDF]

open access: yes, 2017
BACKGROUND: Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS: We performed a multicenter, prospective, open-label study to determine whether 5 g of intravenous idarucizumab would be ...
Bernstein, Richard A.   +20 more
core   +1 more source

Implications of apixaban for dental treatments [PDF]

open access: yes, 2016
Anticoagulation therapy is used in several conditions to prevent or treat thromboembolism. Recently, new oral anticoagulants have been introduced as alternatives to warfarin and acenocoumarol.
Albaladejo Martínez, Alberto   +1 more
core   +1 more source

What’s new about sample quality in routine coagulation testing? [PDF]

open access: yes, 2015
Today, laboratories are very much different than they were decades ago. They have improved instruments to work with, multiple off-site collection points, more competent personnel, a greater analyte panel and quality requirements for those analytes ...
Freitas, Francisco
core  

Crotalus atrox venom preconditioning increases plasma fibrinogen and reduces perioperative hemorrhage in a rat model of surgical brain injury. [PDF]

open access: yes, 2017
Perioperative bleeding is a potentially devastating complication in neurosurgical patients, and plasma fibrinogen concentration has been identified as a potential modifiable risk factor for perioperative bleeding.
Applegate, Richard   +12 more
core   +1 more source

Fabrication and characterization of chitosan nanoparticles and collagen-loaded polyurethane nanocomposite membrane coated with heparin for atrial septal defect (ASD) closure [PDF]

open access: yes, 2017
Atrial septal defect (ASD) constitutes 30–40% of all congenital heart diseases in adults. The most common complications in the treatment of ASD are embolization of the device and thrombosis formation.
Ayyar, M.   +3 more
core   +1 more source

Evaluation of anticoagulant and thrombolytic activity of Berberis orthobotrys in animal model

open access: yesBangladesh Journal of Pharmacology, 2018
Fundamental to this research was the evaluation of anticoagulant and thrombolytic potential of Berberis orthobotrys using clotting time, prothrombin time and activated partial thromboplastin time performed at 2.5, 5, 10% concentration.
. Alamgeer   +3 more
doaj   +1 more source

Effects of hemoglobin-based oxygen carriers on blood coagulation. [PDF]

open access: yes, 2014
For many decades, Hemoglobin-based oxygen carriers (HBOCs) have been central in the development of resuscitation agents that might provide oxygen delivery in addition to simple volume expansion.
Holtby, Randall J   +2 more
core   +3 more sources

Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study

open access: yesBiomedical and Biotechnology Research Journal, 2019
Background: The study was designed for establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers.
Rehan Ahmed   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy